Drugs / Autologous DC-vaccines
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03119025 | May 2015 → Feb 2018 | chronic hepatitis C virus infection | Russian Academy of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous DC-vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03119025 ↗ |
| Modality | Cell therapy | “autologous monocyte-derived dendritic cells” NCT03119025 ↗ |
| Route | Other | “via intracutaneous injection” NCT03119025 ↗ |